Items in cart [1] Questions? Call 888-624-8373

PAPERBACK list:$21.00 Web:$18.90 add to cart PDF BOOK your price: $16.50 add to cart Rights & Permissions Free Resources Display this book on your site! Related Titles The Threat of Pandemic Influenza: Are We Ready? Workshop Summary Immunization Safety Review: Vaccines and Autism Other Related Titles Vaccine Supply and Innovation (1985) Institute of Medicine (IOM) Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Page 201   E-mail  Facebook  Digg  Stumble  Twitter More Page 201 Front Matter (R1-R12) 1 Summary (1-13) 2 Vaccines: Past, Present, and Future (14-26) 3 Vaccine Availability: Concerns, Barriers, and Impediments (27-44) 4 Economic Aspects of Vaccine Innovation and Manufacturing (45-64) 5 Vaccine Injury (65-84) 6 Liability for the Production and Sale of Vaccines (85-122) 7 An Approach to Problems of Communication, Coordination, and Collaboration in Vaccine Policy (123-135) 8 Vaccine Injury Compensation and Liability Remedies (136-160) Appendix A: Product License Holders (161-163) Appendix B: A Vaccine Supply Public Insurance Option (164-165) Appendix C: No-Fault Vaccine Injury Insurance (166-170) Appendix D: Injury Compensation Systems in the United States (171-175) Appendix E: Vaccine-Injury Compensation in Other Countries (176-182) Appendix F: Proposed Vaccine-Injury Compensation Systems (183-191) Appendix G: Mechanisms Used in Other Countries to Ensure Vaccine Supply (192-193) Appendix H: Background Papers (194-195) Appendix I: Biographical Notes on Committee Members and Consultants (196-200) Appendix J: Recommendations for the Proposed Vaccine Commission (201-202) Index (203-210)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 201
Appendix J RECOMMENDATIONS FOR THE PROPOSED VACCINE COMMISSION In developing a slate of candidates for possible membership on the board of directors for the proposed vaccine commission (Chapter 7), recommendations should be sought from all relevant groups, including but not limited to: Presidents of the National Academy of Sciences and the Institute of Medicine . . American Academy of Pediatrics Federated Council on Internal Medicine · American Medical Association . . . . Infectious Diseases Society of America National Medical Association American Nurses' Association American Public Health Association American Bar Association Pharmaceutical Manufacturers Association American Pharmaceutical Association national voluntary health associations public interest groups third-party payers of medical care international health organizations social science organizations involved in areas relevant to vaccine use. 201

OCR for page 202

Representative terms from entire chapter:

vaccine commission